Activation mechanism of human soluble guanylate cyclase by stimulators and activators
Soluble guanylate cyclase (sGC) is a validated drug target for cardiovascular diseases. Here, the authors report structures of human sGC in complex with NO and sGC stimulators or activator, providing insight into the mechanism of sGC activation by pharmacological compounds.
Guardado en:
Autores principales: | Rui Liu, Yunlu Kang, Lei Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/52e3ea2fe9834548a8209df389102dd7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer
por: Maximilian W. Schenk, et al.
Publicado: (2021) -
Differential calcium signaling by cone specific guanylate cyclase-activating proteins from the zebrafish retina.
por: Alexander Scholten, et al.
Publicado: (2011) -
Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
por: Aikaterini I. Argyriou, et al.
Publicado: (2021) -
Overexpression of guanylate cyclase activating protein 2 in rod photoreceptors in vivo leads to morphological changes at the synaptic ribbon.
por: Natalia López-del Hoyo, et al.
Publicado: (2012) -
Soluble variants of human recombinant glutaminyl cyclase.
por: Cristiana Castaldo, et al.
Publicado: (2013)